Priority Setting Using the ABC Framework
The nurse must prioritize the patient with the most immediate threat to airway, breathing, or circulation. The patient with chronic obstructive pulmonary disease (COPD) who is using accessory muscles and has an SpO2 of
88% is demonstrating signs of acute respiratory distress and hypoxemia, which takes precedence over pain, elevated blood pressure with nausea, or routine postoperative needs.
Pathophysiology and Clinical Reasoning
In a patient with COPD, an acute exacerbation (AECOPD) leads to worsened airflow limitation and gas trapping. This increases the work of breathing, and the body recruits accessory muscles—such as the sternocleidomastoid and scalene muscles—to try to maintain adequate ventilation. The use of these muscles is a critical clinical sign indicating that the patient is in severe respiratory distress and at risk of impending respiratory muscle fatigue and failure
[1].
The SpO2 reading of
88% indicates significant
hypoxemia. In the context of acute respiratory failure, hypoxemia is associated with high mortality if not promptly corrected
[2]. The body’s compensatory mechanisms are failing, and without immediate intervention—such as optimizing oxygenation delivery, which evidence suggests may include modalities like high-flow nasal cannula or non-invasive ventilation for severe cases—the patient can rapidly decompensate
[2]. This represents a clear "Breathing" problem in the ABC (Airway, Breathing, Circulation) priority framework, which is always the highest priority after securing an airway.
Analysis of Other Options
-
Option 1 (Pain): A headache rated 6/10 is a comfort issue. While pain management is an important nursing responsibility, it is not life-threatening and can be safely delayed until the patient with respiratory distress is stabilized.
-
Option 3 (Elevated BP with Nausea): A blood pressure of
160/100 mmHg with nausea is concerning and requires follow-up, as it could indicate hypertensive urgency or other complications. However, this is a "Circulation" issue that, while serious, is not as immediately critical as an active "Breathing" compromise where the patient’s compensatory mechanisms are visibly failing.
-
Option 4 (Postoperative Ambulation): A request for assistance to ambulate on postoperative day 2 is a routine safety and activity need. It is the lowest priority among the presented scenarios.
Application of Evidence to Nursing Assessment
For the nurse, the assessment must go beyond just looking at the SpO2 number. The combination of a low oxygen saturation and the physical sign of accessory muscle use is a powerful indicator of increased work of breathing and physiological decompensation in AECOPD. Research on perioperative hypoxemia management emphasizes that early identification and intervention for respiratory deterioration are crucial for preventing adverse outcomes . The nurse’s immediate priority is to assess this patient first, apply oxygen as prescribed, position the patient to maximize ventilation (e.g., high Fowler’s position), and promptly notify the healthcare provider for further orders, which may include bronchodilators, corticosteroids, or escalation to non-invasive ventilatory support. This aligns with the goal of preventing progression to overt respiratory failure, a condition with a complex and unpredictable clinical course in advanced COPD .
References (research sources)
- [1]
Severity-adapted graded exercise rehabilitation reduces systemic inflammation and improves functional capacity in hospitalized AECOPD: an assessor-blinded randomized controlled trial.RCT/clinical trialZeng H, Chen Y, Ran H, Zhao D, Wang Y, Fu D, Yang N, Luo J, Ma L, Hu Q, Huang L, Li C, Luo L, Liu R. (2026) · DOI: 10.3389/fphys.2026.1767608
- [2]
Comparing high-flow nasal cannula oxygen and non-invasive ventilation to standard oxygenation in non-selected intensive care unit patients admitted for acute hypoxaemic respiratory failure: protocol for the KISS (Key oxygenation Interventions in Surgical and non-Surgical patients) adaptive randomised controlled trial.RCT/clinical trialJaber S, Huguet H, Molinari N, De Jong A. (2025) · DOI: 10.1136/bmjopen-2025-100149